NODDI的U型纤维MRI指标对复发缓解型多发性硬化PIRA风险分层
该单中心纵向研究纳入138例复发缓解型多发性硬化患者,行3T脑MRI并随访中位3.0年,35例发生独立于复发活动的进展。多变量模型纳入SDMT、EDSS及右侧枕颞、顶颞区U型纤维扩散指标,AUC为0.793。加入U型纤维指标可改善临床指标的重分类能力。
要点
- 右侧枕颞、顶颞区U型纤维NDI降低可能与后续PIRA风险相关。
- U型纤维扩散指标可为EDSS和SDMT之外提供补充风险分层信息。
- 该模型为探索性结论,尚需多中心独立队列验证后方可临床应用。
核心结论
- NODDI衍生的U型纤维指标可能补充临床指标用于RRMS患者PIRA风险分层,但需独立多中心验证。
研究设计与样本
- 单中心纵向研究,纳入138例RRMS患者,行3T脑MRI,中位随访3.0年。
- PIRA定义为EDSS恶化且6个月后确认,排除复发前90天内或确认前复发的相关事件。
- 从16个基于图谱的表浅U型纤维束提取指标,经单变量筛选、VIF过滤及多变量逻辑回归构建简化模型。
- 采用五折交叉验证、校准、Brier评分、决策曲线和连续净重分类改善指数评估模型性能。
关键影像表现/征象
- 右侧枕颞区神经突密度指数、右侧顶颞区神经突密度指数及右侧枕颞区各向异性分数被保留入简化模型。
诊断标准与关键数值
- 简化模型AUC为0.793(95%CI 0.693-0.893),Brier评分为0.143。
- 加入U型纤维指标后连续NRI为0.518(95%CI 0.138-0.882,p=0.006),优于仅用SDMT和EDSS的重分类。
临床应用与阅片要点
- 阅片时可关注表浅白质U型纤维区域扩散指标变化,尤其在枕颞和顶颞连接区。
- 该类指标不应单独用于PIRA预测,需结合EDSS和SDMT等临床信息综合判断。
局限性
- 单中心研究设计,模型为探索性,需独立多中心队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Progression independent of relapse activity (PIRA) contributes to disability accumulation in relapsing-remitting multiple sclerosis (RRMS), but magnetic resonance imaging (MRI) markers of its microstructural substrate remain unclear. We evaluated whether U-fiber metrics derived from neurite orientation dispersion and density imaging and diffusion tensor imaging are associated with subsequent PIRA and may support MRI-based risk stratification.
MATERIALS AND METHODS: This single-center longitudinal study included 138 patients with RRMS who underwent 3 T brain MRI and were followed for a median of 3.0 years. PIRA required an Expanded Disability Status Scale (EDSS) worsening confirmed over 6 months; events preceded by a relapse within 90 days or followed by a relapse before the 6-month confirmation assessment were excluded. Metrics were extracted from 16 atlas-based superficial U-fiber bundles. Candidate variables underwent univariable screening, variance inflation factor filtering, and exploratory multivariable logistic regression to construct a reduced model. Performance was assessed using five-fold cross-validation, calibration, Brier score, decision curve analysis, and continuous net reclassification improvement (NRI).
RESULTS: PIRA developed in 35 patients (25.4%). Symbol Digit Modalities Test (SDMT), EDSS, right occipitotemporal neurite density index (NDI), right parietotemporal NDI, and right occipitotemporal FA were retained. The reduced model achieved an AUC of 0.793 (95% confidence interval [CI], 0.693-0.893) and a Brier score of 0.143. Adding U-fiber metrics improved reclassification beyond SDMT and EDSS (continuous NRI, 0.518; 95% CI, 0.138-0.882; p = 0.006).
CONCLUSION: Advanced diffusion MRI-derived U-fiber metrics may complement clinical measures for exploratory PIRA risk stratification in RRMS and warrant validation in independent multicenter cohorts.
引用
- Li, Yan, Shi, et al. NODDI-derived U-Fiber MRI Markers for Risk Stratification of Progression Independent of Relapse Activity in Relapsing-remitting Multiple Sclerosis. Acad Radiol. 2026. PMID: 42637582. doi:10.1016/j.acra.2026.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。